# Regeneration in Cervical Degenerative Myelopathy

> **NCT04631471** · PHASE3 · RECRUITING · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 400 (estimated)

## Conditions studied

- Myelopathy
- Spinal Cord Diseases

## Interventions

- **DRUG:** Ibudilast
- **PROCEDURE:** Cervical decompressive surgery
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT04631471
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-22
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04631471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04631471, "Regeneration in Cervical Degenerative Myelopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04631471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*